BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 119845
Published online Jun 27, 2026. doi: 10.4240/wjgs.119845
New-onset diabetes mellitus after distal pancreatectomy: Incidence, predictors and clinical impact
Zoi Gkiafi, Sofia Rozani
Zoi Gkiafi, Department of Surgery I, Laiko University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens 11527, Attikí, Greece
Sofia Rozani, Department of Surgery II, Aretaieio University Hospital, National and Kapodistrian University of Athens, Athens 11528, Attikí, Greece
Author contributions: Gkiafi Z and Rozani S contributed to data extraction, validation, visualization and writing process at every part of this manuscript.
AI contribution statement: I use Grammarly for language polishing.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Sofia Rozani, MD, PhD, Academic Fellow, Research Fellow, Department of Surgery II, Aretaieio University Hospital, National and Kapodistrian University of Athens, Vasileos Sofias Street 76, Athens 11528, Attikí, Greece. sofrozan@gmail.com
Received: February 7, 2026
Revised: February 25, 2026
Accepted: March 18, 2026
Published online: June 27, 2026
Processing time: 134 Days and 16.5 Hours
Core Tip

Core Tip: New-onset diabetes mellitus is a frequent and clinically important consequence of distal pancreatectomy, driven by loss of β-cell mass and potential impairment of pancreatic remnant perfusion. Its incidence varies widely due to differences in surgical technique, underlying pathology, and patient metabolic status. Key determinants include preoperative glucose intolerance, pancreatic steatosis, patient age, and the volume and vascularization of the remnant gland. Recognizing these risk factors enables improved patient selection, early detection, and tailored follow-up strategies. This review highlights emerging evidence on modifiable operative considerations and underscores the need for targeted research to reduce new-onset diabetes mellitus risk.

Write to the Help Desk